I 

109TH CONGRESS 

1ST SESSION H. R. 1446

To amend the Controlled Substances Act to eliminate the safe-harbor exception for certain packaged pseudoephedrine products used in the manufacture of methamphetamine, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 17, 2005

Mr. SOUDER (for himself, Mr. BURTON of Indiana, Mr. PETERSON of Pennsylvania, Mr. BOEHLERT, Ms. BORDALLO, Mr. CASE, and Mr. KENNEDY

of Minnesota) introduced the following bill; which was referred to the 

Committee on Energy and Commerce, and in addition to the Committee 

on the Judiciary, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL

To amend the Controlled Substances Act to eliminate the 

safe-harbor exception for certain packaged 

pseudoephedrine products used in the manufacture of 

methamphetamine, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Methamphetamine Abuse Prevention Act of 2005’’. 
2 

•HR 1446 IH 

1 (b) TABLE OF CONTENTS.—The table of contents of 

2 this Act is as follows: 

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

TITLE I—METHAMPHETAMINE PRECURSORS 

Subtitle A—Amendments to Controlled Substances Act 

Sec. 101. Regulated transactions in methamphetamine precursor chemical products. 

Sec. 102. Authority to establish production quotas. 

Sec. 103. Penalties; authority for manufacturing; quota. 

Subtitle B—Amendments to Controlled Substances Import and Export Act 

Sec. 111. Restrictions on importation; authority to permit imports for medical, 

scientific, or other legitimate purposes. 

Sec. 112. Notice of importation or exportation; approval of sale or transfer by 

importer or exporter. 

Subtitle C—General Provisions 

Sec. 121. Report by Director of Office of National Drug Control Policy regarding regulation of list I chemicals. 

TITLE II—RESOURCES FOR ENFORCEMENT 

Sec. 201. Authorization of appropriations relating to COPS grants. 

Sec. 202. Expansion of methamphetamine hot spots program to include personnel and equipment for enforcement, prosecution, and cleanup. 

Sec. 203. Special United States attorneys’ program. 

TITLE III—GRANT PROGRAMS 

Subtitle A—Public Health Service Act 

Sec. 301. Grants for services for children of substance abusers. 

Sec. 302. Local grants for treatment of methamphetamine abuse and related 

conditions. 

Subtitle B—Bureau of Justice 

Sec. 303. Methamphetamine precursor monitoring grants. 

3 SEC. 2. FINDINGS. 

4 The Congress finds as follows: 

5 (1) Methamphetamine, ecstasy, and other syn6 thetic drugs are dangerous drugs distributed 

7 throughout the United States. 
3

•HR 1446 IH 

1 (2) The manufacture, distribution, and use of 

2 methamphetamine and other synthetic drugs result 

3 in increased crime, damage to the environment, and 

4 hazardous waste that endanger the public, expensive 

5 cleanup costs often borne by Federal, State, and 

6 local government agencies, and broken families. 

7 (3) The Congress has acted many times to limit 

8 the availability of chemicals and equipment used in 

9 the manufacturing of methamphetamine and other 

10 synthetic drugs. 

11 (4) Pseudoephedrine is one of the basic pre12 cursor chemicals used in the manufacture of meth13 amphetamine. 

14 (5) The Drug Enforcement Administration has 

15 indicated that methamphetamine manufacturers 

16 often obtain pseudoephedrine from retail and whole17 sale distributors, in both bottles and ‘‘blister packs’’, 

18 and that the use of pseudoephedrine tablets in blis19 ter packs is pervasive in the illicit production of 

20 methamphetamine in both small and large clandes21 tine methamphetamine laboratories. 

22 (6) While current law establishes a retail sales 

23 limit of 9 grams for most pseudoephedrine products, 

24 including common cold medicine, there is no such 
4

•HR 1446 IH 

1 limit on the sale of blister-packed pseudoephedrine 

2 products. 

3 (7) The 9 gram limit on bottled 

4 pseudoephedrine allows an individual to purchase ap5 proximately 366 thirty-milligram tablets per trans6 action, which is significantly more than a typical 

7 consumer would need for legitimate purposes. 

8 (8) Reducing the current 9 gram threshold to 

9 6 grams would allow consumers to continue pur10 chasing sufficient medication for legitimate purposes 

11 and would assist efforts to reduce illegal use of the 

12 pseudoephedrine products. 

13 (9) The Drug Enforcement Administration rec14 ommended in March 2002 that retail distribution of 

15 pseudoephedrine tablets in blister packages should 

16 not be exempt from the general retail sales limit. 

17 (10) In recommending legislation to correct the 

18 current disparity in the law between bottled and blis19 ter-packed pseudoephedrine tablets, the Drug En20 forcement Administration stated that ‘‘The removal 

21 of this difference would significantly prevent illicit 

22 access to this methamphetamine precursor and 

23 would be easier for both the government and the in24 dustry to monitor and would increase compliance by 

25 retailers’’. 
5

•HR 1446 IH 

1 (11) In its October 2004 National Synthetic 

2 Drugs Action Plan, the Department of Justice and 

3 the Office of National Drug Control Policy also rec4 ommended that the manufacture, import, export, 

5 and distribution of pseudoephedrine and other syn6 thetic drug precursor chemicals be subject to in7 creased governmental oversight to reduce the danger 

8 of diversion to illegal drug production. 

9 TITLE I—METHAMPHETAMINE 

10 PRECURSORS 

11 Subtitle A—Amendments to 

12 Controlled Substances Act 

13 SEC. 101. REGULATED TRANSACTIONS IN METHAMPHET14 AMINE PRECURSOR CHEMICAL PRODUCTS. 

15 (a) REDUCTION OF RETAIL SALES THRESHOLD.—

16 Section 102(39)(A)(iv)(II) of the Controlled Substances 

17 Act (21 U.S.C. 802(39)(A)(iv)(II)) is amended by striking 

18 ‘‘shall be 9 grams’’ and all that follows and inserting the 

19 following: ‘‘shall be any quantity of pseudoephedrine over 

20 6.0 grams in a single transaction, or any quantity of phen21 ylpropanolamine over 6.0 grams in a single transaction, 

22 which quantity is—

23 ‘‘(aa) with respect to nonliq24 uids, sold in package sizes of not 

25 more than 3.0 grams of 
6

•HR 1446 IH 

1 pseudoephedrine base or 3.0 

2 grams of phenylpropanolamine 

3 base, respectively, and packaged 

4 in blister packs, each blister con5 taining not more than 2 dosage 

6 units, or where the use of blister 

7 packs is technically infeasible, 

8 packaged in unit dose packets or 

9 pouches; and 

10 ‘‘(bb) with respect to liquids, 

11 sold in package sizes of not more 

12 than 3.0 grams of 

13 pseudoephedrine base, or 3.0 

14 grams of phenylpropanolamine 

15 base, respectively; or’’. 

16 (b) ELIMINATION OF BLISTER PACK EXEMPTION.—

17 (1) REGULATED TRANSACTION.—Section 

18 102(39)(A)(iv)(I)(aa) of the Controlled Substances 

19 Act (21 U.S.C. 802(39)(A)(iv)(I)(aa)) is amended by 

20 striking ‘‘, except that’’ and all that follows through 

21 ‘‘1996)’’. 

22 (2) DEFINITION.—Section 102 of the Con23 trolled Substances Act (21 U.S.C. 802) is amend24 ed—

25 (A) by striking paragraph (45); and 
7

•HR 1446 IH 

1 (B) by redesignating paragraph (46) as 

2 paragraph (45). 

3 (3) RULE OF LAW.—To the extent that there 

4 exists a conflict between the amendment made by 

5 paragraph (1) and section 401(d) of the Comprehen6 sive Methamphetamine Control Act of 1996 (21 

7 U.S.C. 802 note), the amendment shall control. 

8 (c) COMBINATIONS INVOLVING DERIVATIVES.—Sec9 tion 102(39) of the Controlled Substances Act (21 U.S.C. 

10 802(39)) is amended—

11 (1) in subparagraph (A)(iv)(I)(aa), by striking 

12 ‘‘the drug contains’’ and all that follows through 

13 ‘‘unless otherwise provided’’ and inserting the fol14 lowing: ‘‘the drug contains ephedrine, 

15 pseudoephedrine, or phenylpropanolamine unless 

16 otherwise provided’’; and 

17 (2) by inserting after and below subparagraph 

18 (B) the following: 

19 ‘‘Each reference in subparagraph (A)(iv) to ephed20 rine, pseudoephedrine, or phenylpropanolamine in21 cludes each of the salts, optical isomers, and salts of 

22 optical isomers of such chemical.’’. 
8

•HR 1446 IH 

1 SEC. 102. AUTHORITY TO ESTABLISH PRODUCTION 

2 QUOTAS. 

3 Section 306 of the Controlled Substances Act (21 

4 U.S.C. 826) is amended—

5 (1) in subsection (a), by inserting ‘‘and for 

6 ephedrine, pseudoephedrine, and phenylpropanola7 mine’’ after ‘‘for each basic class of controlled sub8 stance in schedules I and II’’; 

9 (2) in subsection (b), by inserting ‘‘or for 

10 ephedrine, pseudoephedrine, or phenylpropanola11 mine’’ after ‘‘for each basic class of controlled sub12 stance in schedule I or II’’ each place such term ap13 pears; 

14 (3) in subsection (c), in the first sentence, by 

15 inserting ‘‘and for ephedrine, pseudoephedrine, and 

16 phenylpropanolamine’’ after ‘‘for the basic classes of 

17 controlled substances in schedules I and II’’; 

18 (4) in subsection (d), by inserting ‘‘or ephed19 rine, pseudoephedrine, or phenylpropanolamine’’ 

20 after ‘‘that basic class of controlled substance’’; 

21 (5) in subsection (e), by inserting ‘‘or for 

22 ephedrine, pseudoephedrine, or phenylpropanola23 mine’’ after ‘‘for a basic class of controlled sub24 stance in schedule I or II’’ each place such term ap25 pears; 

26 (6) in subsection (f)—
9

•HR 1446 IH 

1 (A) by inserting ‘‘or ephedrine, 

2 pseudoephedrine, or phenylpropanolamine’’ 

3 after ‘‘controlled substances in schedules I and 

4 II’’; 

5 (B) by inserting ‘‘or of ephedrine, 

6 pseudoephedrine, or phenylpropanolamine’’ 

7 after ‘‘the manufacture of a controlled sub8 stance’’; and 

9 (C) by inserting ‘‘or chemicals’’ after 

10 ‘‘such incidentally produced substances’’; and 

11 (7) by adding at the end the following sub12 section: 

13 ‘‘(g) Each reference in this section to ephedrine, 

14 pseudoephedrine, or phenylpropanolamine includes each of 

15 the salts, optical isomers, and salts of optical isomers of 

16 such chemical.’’. 

17 SEC. 103. PENALTIES; AUTHORITY FOR MANUFACTURING; 

18 QUOTA. 

19 Section 402(b) of the Controlled Substances Act (21 

20 U.S.C. 842(b)) is amended by inserting after ‘‘manufac21 ture a controlled substance in schedule I or II’’ the fol22 lowing: ‘‘, or ephedrine, pseudoephedrine, or phenyl23 propanolamine or any of the salts, optical isomers, or salts 

24 of optical isomers of such chemical,’’
10

•HR 1446 IH 

1 Subtitle B—Amendments to Con2 trolled Substances Import and 

3 Export Act 

4 SEC. 111. RESTRICTIONS ON IMPORTATION; AUTHORITY TO 

5 PERMIT IMPORTS FOR MEDICAL, SCIENTIFIC, 

6 OR OTHER LEGITIMATE PURPOSES. 

7 Section 1002(a) of the Controlled Substances Import 

8 and Export Act (21 U.S.C. 952(a)) is amended—

9 (1) in the matter preceding paragraph (1), by 

10 inserting ‘‘or ephedrine, pseudoephedrine, or phenyl11 propanolamine,’’ after ‘‘schedule III, IV, or V of title 

12 II,’’; 

13 (2) in paragraph (1), by inserting ‘‘, and of 

14 ephedrine, pseudoephedrine, and phenylpropanola15 mine, ’’ after ‘‘coca leaves’’; and 

16 (3) by adding at the end the following sub17 sections: 

18 ‘‘(d)(1) With respect to a registrant under section 

19 1008 who is authorized under subsection (a)(1) to import 

20 ephedrine, pseudoephedrine, or phenylpropanolamine, at 

21 any time during the year the registrant may apply for an 

22 increase in the amount of such chemical that the reg23 istrant is authorized to import, and the Attorney General 

24 may approve the application if the Attorney General deter25 mines that the approval is necessary to provide for med-
11

•HR 1446 IH 

1 ical, scientific, or other legitimate purposes regarding the 

2 chemical. 

3 ‘‘(2) Not later than 60 days after receiving an appli4 cation under paragraph (1), the Attorney General shall 

5 approve or deny the application. In approving such an ap6 plication, the Attorney General shall specify the period of 

7 time for which the approval is in effect, or shall provide 

8 that the approval is effective until the registrant involved 

9 is notified by the Attorney General that the approval is 

10 terminated. 

11 ‘‘(e) Each reference in this section to ephedrine, 

12 pseudoephedrine, or phenylpropanolamine includes each of 

13 the salts, optical isomers, and salts of optical isomers of 

14 such chemical.’’. 

15 SEC. 112. NOTICE OF IMPORTATION OR EXPORTATION; AP16 PROVAL OF SALE OR TRANSFER BY IM17 PORTER OR EXPORTER. 

18 (a) IN GENERAL.—Section 1018 of the Controlled 

19 Substances Import and Export Act (21 U.S.C. 971) is 

20 amended—

21 (1) by redesignating subsections (d) and (e) as 

22 subsections (e) and (f), respectively; and 

23 (2) by inserting after subsection (c) the fol24 lowing subsection: 
12

•HR 1446 IH 

1 ‘‘(d)(1)(A) Information provided in a notice under 

2 subsection (a) shall include the name of the person to 

3 whom the importer or exporter involved intends to transfer 

4 the listed chemical involved. 

5 ‘‘(B) After a notice under subsection (a) is provided 

6 to the Attorney General, if circumstances change and the 

7 importer or exporter will not be transferring the listed 

8 chemical to the transferee identified in the notice, the im9 porter or exporter may not transfer the listed chemical 

10 until after the expiration of the 15-day period beginning 

11 on the date on which the importer or exporter updates 

12 the notice to identify the most recent prospective trans13 feree. The preceding sentence applies with respect to 

14 changing circumstances regarding a transferee identified 

15 in an update to the same extent and in the same manner 

16 as such sentence applies with respect to changing cir17 cumstances regarding a transferee identified in a notice 

18 under subsection (a). 

19 ‘‘(C) If in reliance on subsection (b) an importer or 

20 exporter does not provide a notice under subsection (a) 

21 with respect to an importation or exportation, but cir22 cumstances change and the importer or exporter will not 

23 be transferring the listed chemical to a regular customer, 

24 the importer or exporter may not transfer the listed chem25 ical until after the expiration of the 15-day period begin-
13

•HR 1446 IH 

1 ning on the date on which the importer or exporter notifies 

2 the Attorney General of the most recent prospective trans3 feree. The preceding sentence applies with respect to 

4 changing circumstances regarding a transferee identified 

5 in a notice under such sentence to the same extent and 

6 in the same manner as such sentence applies with respect 

7 to the original changing circumstances in which the listed 

8 chemical was not transferred to a regular customer. 

9 ‘‘(2) With respect to the transfer of a listed chemical 

10 by an importer or exporter: 

11 ‘‘(A) The Attorney General may, in accordance 

12 with the same procedures as apply under subsection 

13 (c)(2), order the suspension of a transfer of the list14 ed chemical by the importer or exporter, other than 

15 a transfer to a regular customer of the importer or 

16 exporter, on the ground that the chemical may be di17 verted to the illegal or clandestine manufacture of a 

18 controlled substance, subject to the Attorney General 

19 ordering such suspension before the expiration of the 

20 15-day period that applies with respect to the impor21 tation or exportation under subparagraph (B) or (C) 

22 of paragraph (1), as the case may be. 

23 ‘‘(B) From and after the time when the Attor24 ney General provides written notice of the order 

25 under subparagraph (A) (including a statement of 
14

•HR 1446 IH 

1 the legal and factual basis for the order) to the im2 porter or exporter, the importer or exporter may not 

3 carry out the transfer. 

4 ‘‘(3) For purposes of this subsection: 

5 ‘‘(A) The terms ‘importer’ and ‘exporter’ mean 

6 a regulated person who imports or exports a listed 

7 chemical, respectively. 

8 ‘‘(B) The term ‘transfer’, with respect to a list9 ed chemical, includes the sale of the chemical. 

10 ‘‘(C) The term ‘transferee’ means a person to 

11 whom an importer or exporter transfers a listed 

12 chemical.’’. 

13 (b) CONFORMING AMENDMENT.—Section 1010(d)(5) 

14 of the Controlled Substances Import and Export Act (21 

15 U.S.C. 960(d)(5)) is amended by striking ‘‘section 

16 1018(e)(2) or (3)’’ and inserting ‘‘paragraph (2) or (3) 

17 of section 1018(f)’’. 

18 Subtitle C—General Provisions 

19 SEC. 121. REPORT BY DIRECTOR OF OFFICE OF NATIONAL 

20 DRUG CONTROL POLICY REGARDING REGU21 LATION OF LIST I CHEMICALS. 

22 Not later than one year after the date of the enact23 ment of this Act, the Director of the Office of National 

24 Drug Control Policy, in consultation with the Attorney 

25 General, shall submit to the Congress a report that—
15

•HR 1446 IH 

1 (1) provides a recommendation by the Director 

2 of whether some or all list I chemicals should be in3 cluded in schedule V of the schedules of controlled 

4 substances; and 

5 (2) provides such additional recommendations 

6 regarding the regulation of list I chemicals as the 

7 Director elects to provide to the Congress. 

8 TITLE II—RESOURCES FOR 

9 ENFORCEMENT 

10 SEC. 201. AUTHORIZATION OF APPROPRIATIONS RELATING 

11 TO COPS GRANTS. 

12 (a) IN GENERAL.—In addition to any other funds au13 thorized to be appropriated for fiscal year 2006 for grants 

14 under part Q of title I of the Omnibus Crime Control and 

15 Safe Streets Act of 1968 (42 U.S.C. 3796dd et seq.), com16 monly known as the COPS program, there are authorized 

17 to be appropriated $15,000,000 for such purpose to pro18 vide training to State and local prosecutors and law en19 forcement agents for the investigation and prosecution of 

20 methamphetamine offenses. 

21 (b) RURAL SET-ASIDE.—Of amounts made available 

22 under subsection (a), $3,000,000 shall be available only 

23 for prosecutors and law enforcement agents for rural com24 munities. 
16

•HR 1446 IH 

1 SEC. 202. EXPANSION OF METHAMPHETAMINE HOT SPOTS 

2 PROGRAM TO INCLUDE PERSONNEL AND 

3 EQUIPMENT FOR ENFORCEMENT, PROSECU4 TION, AND CLEANUP. 

5 Section 1701(d) of the Omnibus Crime Control and 

6 Safe Streets Act of 1968 (42 U.S.C. 3796dd(d)) is amend7 ed—

8 (1) in paragraph (11) by striking ‘‘and’’ at the 

9 end; 

10 (2) in paragraph (12) by striking the period at 

11 the end and inserting ‘‘; and’’; and 

12 (3) by adding at the end the following: 

13 ‘‘(13) hire personnel and purchase equipment to 

14 assist in the enforcement and prosecution of meth15 amphetamine offenses and the cleanup of meth16 amphetamine-affected areas.’’. 

17 SEC. 203. SPECIAL UNITED STATES ATTORNEYS’ PROGRAM. 

18 (a) IN GENERAL.—The Attorney General shall allo19 cate any amounts appropriated pursuant to the authoriza20 tion under subsection (c) for the hiring and training of 

21 special assistant United States attorneys. 

22 (b) USE OF FUNDS.—The funds allocated under sub23 section (a) shall be used to—

24 (1) train local prosecutors in techniques used to 

25 prosecute methamphetamine cases, including the 
17 

•HR 1446 IH 

1 presentation of evidence related to the manufacture 

2 of methamphetamine; 

3 (2) train local prosecutors in Federal and State 

4 laws involving methamphetamine manufacture or 

5 distribution; 

6 (3) cross-designate local prosecutors as special 

7 assistant United States attorneys; and 

8 (4) hire additional local prosecutors who— 

9 (A) with the approval of the United States 

10 attorney, shall be cross-designated to prosecute 

11 both Federal and State methamphetamine 

12 cases; and 

13 (B) shall be assigned a caseload, whether 

14 in State court or Federal court, that gives the 

15 highest priority to cases in which— 

16 (i) charges related to methamphet17 amine manufacture or distribution are sub18 mitted by law enforcement for consider19 ation; and 

20 (ii) the defendant has been previously 

21 convicted of a crime related to meth22 amphetamine manufacture or distribution. 

23 (c) AUTHORIZATION OF APPROPRIATIONS.—There 

24 are authorized to be appropriated $5,000,000 for each of 
18

•HR 1446 IH 

1 the fiscal years 2006 and 2007 to carry out the provisions 

2 of this section. 

3 TITLE III—GRANT PROGRAMS 

4 Subtitle A—Public Health Service 

5 Act 

6 SEC. 301. GRANTS FOR SERVICES FOR CHILDREN OF SUB7 STANCE ABUSERS. 

8 Section 519 of the Public Health Service Act (42 

9 U.S.C. 290bb–25) is amended—

10 (1) in subsection (b), by inserting after para11 graph (8) the following: 

12 ‘‘(9) Development of drug endangered children 

13 rapid response teams that will intervene on behalf of 

14 children exposed to methamphetamine as a result of 

15 residing or being present in a home-based clandes16 tine drug laboratory.’’; and 

17 (2) in subsection (o)—

18 (A) by striking ‘‘For the purpose’’ and in19 serting the following: 

20 ‘‘(1) IN GENERAL.—For the purpose’’; and 

21 (B) by adding at the end the following: 

22 ‘‘(2) DRUG ENDANGERED CHILDREN RAPID RE23 SPONSE TEAMS.—There are authorized to be appro24 priated $2,500,000 for each of the fiscal years 2006 
19

•HR 1446 IH 

1 and 2007 to carry out the provisions of subsection 

2 (b)(9).’’. 

3 SEC. 302. LOCAL GRANTS FOR TREATMENT OF METH4 AMPHETAMINE ABUSE AND RELATED CONDI5 TIONS. 

6 Subpart 1 of part B of title V of the Public Health 

7 Service Act (42 U.S.C. 290bb et seq.) is amended—

8 (1) by redesignating the section 514 that re9 lates to methamphetamine and appears after section 

10 514A as section 514B; 

11 (2) in section 514B, as redesignated—

12 (A) by amending subsection (a)(1) to read 

13 as follows: 

14 ‘‘(1) GRANTS AUTHORIZED.—The Secretary 

15 may award grants to States, political subdivisions of 

16 States, American Indian Tribes, and private, non17 profit entities to provide treatment for methamphet18 amine abuse.’’; 

19 (B) by amending subsection (b) to read as 

20 follows: 

21 ‘‘(b) PRIORITY FOR RURAL AREAS.—In awarding 

22 grants under subsection (a), the Secretary shall give pri23 ority to entities that will serve rural areas experiencing 

24 an increase in methamphetamine abuse.’’; and 
20

•HR 1446 IH 

1 (C) in subsection (d)(1), by striking 

2 ‘‘2000’’ and all that follows and inserting 

3 ‘‘2005 and such sums as may be necessary for 

4 each of fiscal years 2006 through 2009’’; and 

5 (3) by inserting after section 514B, as redesig6 nated, the following: 

7 ‘‘SEC. 514C. METHAMPHETAMINE RESEARCH, TRAINING, 

8 AND TECHNICAL ASSISTANCE CENTER. 

9 ‘‘(a) PROGRAM AUTHORIZED.—The Secretary, acting 

10 through the Administrator, and in consultation with the 

11 Director of the National Institutes of Health, shall award 

12 grants to, or enter into contracts with, public or private, 

13 nonprofit entities to establish a research, training, and 

14 technical assistance center to carry out the activities de15 scribed in subsection (d). 

16 ‘‘(b) APPLICATION.—A public or private, nonprofit 

17 entity seeking a grant or contract under subsection (a) 

18 shall submit an application to the Secretary at such time, 

19 in such manner, and containing such information as the 

20 Secretary may require. 

21 ‘‘(c) CONDITION.—In awarding grants or entering 

22 into contracts under subsection (a), the Secretary shall en23 sure that not less than 1 of the centers will focus on meth24 amphetamine abuse in rural areas. 
21

•HR 1446 IH 

1 ‘‘(d) AUTHORIZED ACTIVITIES.—Each center estab2 lished under this section shall—

3 ‘‘(1) engage in research and evaluation of the 

4 effectiveness of treatment modalities for the treat5 ment of methamphetamine abuse; 

6 ‘‘(2) disseminate information to public and pri7 vate entities on effective treatments for methamphet8 amine abuse; 

9 ‘‘(3) provide direct technical assistance to 

10 States, political subdivisions of States, and private 

11 entities on how to improve the treatment of meth12 amphetamine abuse; and 

13 ‘‘(4) provide training on the effects of meth14 amphetamine use and on effective ways of treating 

15 methamphetamine abuse to substance abuse treat16 ment professionals and community leaders. 

17 ‘‘(e) REPORTS.—Each grantee or contractor under 

18 this section shall annually submit a report to the Adminis19 trator that contains—

20 ‘‘(1) a description of the previous year’s activi21 ties of the center established under this section; 

22 ‘‘(2) effective treatment modalities undertaken 

23 by the center; and 

24 ‘‘(3) evidence to demonstrate that such treat25 ment modalities were successful. 
22

•HR 1446 IH 

1 ‘‘(f) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $3,000,000 for fiscal year 2006 and such sums as may 

4 be necessary for each of fiscal years 2007 and 2008.’’. 

5 Subtitle B—Bureau of Justice 

6 SEC. 303. METHAMPHETAMINE PRECURSOR MONITORING 

7 GRANTS. 

8 (a) GRANTS AUTHORIZED.—The Attorney General, 

9 acting through the Bureau of Justice Assistance, may 

10 award grants to States to establish methamphetamine pre11 cursor monitoring programs. 

12 (b) PURPOSE.—The purpose of the grant program es13 tablished under this section is to—

14 (1) prevent the sale of methamphetamine pre15 cursors, such as pseudoephedrine, to individuals in 

16 quantities so large that the only reasonable purpose 

17 of the purchase would be to manufacture meth18 amphetamine; 

19 (2) educate businesses that legally sell meth20 amphetamine precursors of the need to balance the 

21 legitimate need for lawful access to medication with 

22 the risk that those substances may be used to manu23 facture methamphetamine; and 

24 (3) recalibrate existing prescription drug moni25 toring programs designed to track the sale of con-
23

•HR 1446 IH 

1 trolled substances to also track the sale of 

2 pseudoephedrine in any amount greater than 6 

3 grams. 

4 (c) USE OF GRANT FUNDS.—Grant funds awarded 

5 to States under this section may be used to—

6 (1) implement a methamphetamine precursor 

7 monitoring program, including hiring personnel and 

8 purchasing computer hardware and software de9 signed to monitor methamphetamine precursor pur10 chases; 

11 (2) expand existing methamphetamine pre12 cursor or prescription drug monitoring programs to 

13 accomplish the purposes described in subsection (b); 

14 (3) pay for training and technical assistance for 

15 law enforcement personnel and employees of busi16 nesses that lawfully sell substances, which may be 

17 used as methamphetamine precursors; 

18 (4) improve information sharing between adja19 cent States through enhanced connectivity; or 

20 (5) make grants to subdivisions of the State to 

21 implement methamphetamine precursor monitoring 

22 programs. 

23 (d) APPLICATION.—Any State seeking a grant under 

24 this section shall submit an application to the Attorney 
24

•HR 1446 IH 

1 General at such time, in such manner, and containing 

2 such information as the Attorney General may require. 

3 (e) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated $5,000,000 for each of 

5 the fiscal years 2006 and 2007 to carry out the provisions 

6 of this section.

Æ